Anticipated Phase 3 Trial of Hydronidone for Treating Liver Fibrosis in Chronic Hepatitis B

Anticipated Phase 3 Trial of Hydronidone for Treating Liver Fibrosis in Chronic Hepatitis B

Source: Contagion Live

With valid phase 2 results, hydronidone could pave the way for first antifibrotic treatment in chronic liver disease.

Chronic Hepatitis B virus symbol. Image credits: Unsplash
A multicenter Phase 3 clinical trial is underway to evaluate the efficacy of hydronidone, a novel antifibrotic agent, in reversing liver fibrosis among patients with chronic hepatitis B (CHB)…. [4120 chars]

Read more